VAXX Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2023-11-03 | Paula Molina Rene | officer | 0 | 0 | 0.00 | 0.00 | ||
| 2023-10-02 | Powchik Peter | director | 159,744 | A-Award | A | 159,744 | 1.27 | 202,875.00 |
| 2023-10-01 | Ray Sumita | officer | 0 | 0 | 0.00 | 0.00 | ||
| 2023-09-06 | Prime Movers Lab Fund I LP | 10 percent owner | 8,759,064 | S-Sale | D | 5,308 | 1.88 | 9,991.00 |
| 2023-09-07 | Prime Movers Lab Fund I LP | 10 percent owner | 8,738,752 | S-Sale | D | 20,312 | 1.79 | 36,302.00 |
| 2023-09-08 | Prime Movers Lab Fund I LP | 10 percent owner | 8,713,663 | S-Sale | D | 25,089 | 1.67 | 41,899.00 |
| 2023-09-06 | Prime Movers Lab Fund I LP | 10 percent owner | 3,612,849 | S-Sale | D | 2,189 | 1.88 | 4,120.00 |
| 2023-09-07 | Prime Movers Lab Fund I LP | 10 percent owner | 3,604,471 | S-Sale | D | 8,378 | 1.79 | 14,973.00 |
| 2023-09-08 | Prime Movers Lab Fund I LP | 10 percent owner | 3,594,122 | S-Sale | D | 10,349 | 1.67 | 17,283.00 |
| 2023-09-06 | Prime Movers Lab Fund I LP | 10 percent owner | 2,063,776 | S-Sale | D | 1,251 | 1.88 | 2,355.00 |
| 2023-09-07 | Prime Movers Lab Fund I LP | 10 percent owner | 2,058,990 | S-Sale | D | 4,786 | 1.79 | 8,554.00 |
| 2023-09-08 | Prime Movers Lab Fund I LP | 10 percent owner | 2,053,079 | S-Sale | D | 5,911 | 1.67 | 9,871.00 |
| 2023-09-06 | Prime Movers Lab Fund I LP | 10 percent owner | 1,472,208 | S-Sale | D | 892 | 1.88 | 1,679.00 |
| 2023-09-07 | Prime Movers Lab Fund I LP | 10 percent owner | 1,468,795 | S-Sale | D | 3,413 | 1.79 | 6,100.00 |
| 2023-09-08 | Prime Movers Lab Fund I LP | 10 percent owner | 1,464,578 | S-Sale | D | 4,217 | 1.67 | 7,042.00 |
| 2023-09-06 | Prime Movers Lab Fund I LP | 10 percent owner | 835,992 | S-Sale | D | 507 | 1.88 | 954.30 |
| 2023-09-07 | Prime Movers Lab Fund I LP | 10 percent owner | 834,053 | S-Sale | D | 1,939 | 1.79 | 3,465.00 |
| 2023-09-08 | Prime Movers Lab Fund I LP | 10 percent owner | 831,658 | S-Sale | D | 2,395 | 1.67 | 4,000.00 |
| 2023-06-20 | HORNIG GEORGE R | director | 132,352 | A-Award | A | 132,352 | 2.21 | 292,498.00 |
| 2023-06-20 | Smith James Alan | director | 132,352 | A-Award | A | 132,352 | 2.21 | 292,498.00 |
| 2023-06-20 | Ogilvie Landon E | director | 132,352 | A-Award | A | 132,352 | 2.21 | 292,498.00 |
| 2023-06-20 | Eade Katherine A. | director | 132,352 | A-Award | A | 132,352 | 2.21 | 292,498.00 |
| 2023-06-20 | TOLEDANO GABRIELLE B | director | 132,352 | A-Award | A | 132,352 | 2.21 | 292,498.00 |
| 2023-06-20 | Diamandis Peter | director | 132,352 | A-Award | A | 132,352 | 2.21 | 292,498.00 |
| 2023-06-20 | Powchik Peter | director | 132,352 | A-Award | A | 132,352 | 2.21 | 292,498.00 |
| 2023-04-26 | Diamandis Peter | director | 906,141 | M-Exempt | A | 46,500 | 1.21 | 56,265.00 |
| 2023-04-26 | Diamandis Peter | director | 859,641 | M-Exempt | A | 429,037 | 0.57 | 244,551.00 |
| 2023-04-26 | Diamandis Peter | director | 732,642 | M-Exempt | D | 46,500 | 1.21 | 56,265.00 |
| 2023-04-26 | Diamandis Peter | director | 99,009 | M-Exempt | D | 429,037 | 0.57 | 244,551.00 |
| 2023-02-01 | Smith James Alan | director | 54,202 | I | 0 | 0.00 | 0.00 | |
| 2023-02-01 | Smith James Alan | director | 8,058 | D | 0 | 0.00 | 0.00 | |
| 2023-03-07 | Hu Mei Mei | director, 10 percent owner, officer: See Remarks | 620,000 | A-Award | A | 620,000 | 2.29 | 1,419,800.00 |
| 2023-03-07 | Hu Mei Mei | director, 10 percent owner, officer: See Remarks | 73,928 | A-Award | A | 73,928 | 2.29 | 169,295.00 |
| 2023-03-07 | Reese Lou | director, officer: See Remarks | 620,000 | A-Award | A | 620,000 | 2.29 | 1,419,800.00 |
| 2023-03-07 | Reese Lou | director, officer: See Remarks | 301,188 | A-Award | A | 301,188 | 2.29 | 689,721.00 |
| 2023-03-07 | Reese Lou | director, officer: See Remarks | 61,607 | A-Award | A | 61,607 | 2.29 | 141,080.00 |
| 2023-03-07 | Pesile Jason | officer: See Remarks | 32,700 | A-Award | A | 32,700 | 2.29 | 74,883.00 |
| 2023-03-07 | Paula Molina Rene | officer: See Remarks | 116,612 | A-Award | A | 116,612 | 2.29 | 267,041.00 |
| 2023-03-07 | Palm Ulo | officer: See Remarks | 123,418 | A-Award | A | 123,418 | 2.29 | 282,627.00 |
| 2023-02-01 | TOLEDANO GABRIELLE B | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2023-02-01 | Eade Katherine A. | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2023-02-01 | Smith James Alan | director | 12,268 | I | 0 | 0.00 | 0.00 | |
| 2023-02-01 | Smith James Alan | director | 8,058 | D | 0 | 0.00 | 0.00 | |
| 2023-02-01 | Ogilvie Landon E | director | 32,850 | I | 0 | 0.00 | 0.00 | |
| 2023-01-23 | Prime Movers Lab Fund I LP | director | 8,764,372 | S-Sale | D | 405,217 | 3.35 | 1,358,044.00 |
| 2023-01-23 | Prime Movers Lab Fund I LP | director | 2,065,027 | S-Sale | D | 95,475 | 3.35 | 319,975.00 |
| 2022-12-01 | Prime Movers Lab Fund I LP | director | 9,180,710 | S-Sale | D | 270,964 | 2.97 | 805,224.00 |
| 2022-12-02 | Prime Movers Lab Fund I LP | director | 9,169,589 | S-Sale | D | 11,121 | 2.57 | 28,561.00 |
| 2022-12-01 | Prime Movers Lab Fund I LP | director | 2,163,122 | S-Sale | D | 63,843 | 2.97 | 189,722.00 |
| 2022-12-02 | Prime Movers Lab Fund I LP | director | 2,160,502 | S-Sale | D | 2,620 | 2.57 | 6,729.00 |
| 2022-09-06 | Sloss Dakin | director: | 9,451,674 | S-Sale | D | 25,243 | 2.40 | 60,656.00 |
| 2022-01-13 | Guirakhoo Farshad | officer: (Former) Chief Scientific Off. | 116,730 | M-Exempt | D | 10,000 | 0.57 | 5,700.00 |
| 2022-07-29 | Guirakhoo Farshad | officer: (Former) Chief Scientific Off. | 86,730 | M-Exempt | D | 20,000 | 0.57 | 11,400.00 |
| 2022-08-22 | Guirakhoo Farshad | officer: (Former) Chief Scientific Off. | 68,645 | M-Exempt | A | 2,640 | 0.57 | 1,505.00 |
| 2022-08-15 | Guirakhoo Farshad | officer: (Former) Chief Scientific Off. | 66,005 | M-Exempt | A | 26,005 | 0.57 | 14,823.00 |
| 2022-08-15 | Guirakhoo Farshad | officer: (Former) Chief Scientific Off. | 60,725 | M-Exempt | D | 26,005 | 0.57 | 14,823.00 |
| 2022-08-22 | Guirakhoo Farshad | officer: (Former) Chief Scientific Off. | 58,085 | M-Exempt | D | 2,640 | 0.57 | 1,505.00 |
| 2022-07-29 | Guirakhoo Farshad | officer: (Former) Chief Scientific Off. | 40,000 | M-Exempt | A | 20,000 | 0.57 | 11,400.00 |
| 2022-01-13 | Guirakhoo Farshad | officer: (Former) Chief Scientific Off. | 10,000 | M-Exempt | A | 10,000 | 0.57 | 5,700.00 |
| 2022-08-23 | Sloss Dakin | director: | 9,499,674 | S-Sale | D | 83,786 | 2.39 | 199,930.00 |
| 2022-06-21 | Chui James | director: | 129,187 | A-Award | A | 129,187 | 0.00 | 0.00 |
| 2022-06-21 | Diamandis Peter | director: | 129,187 | A-Award | A | 129,187 | 0.00 | 0.00 |
| 2022-06-21 | Diamandis Peter | director | 129,187 | A-Award | A | 129,187 | 2.09 | 270,001.00 |
| 2022-06-21 | HORNIG GEORGE R | director: | 129,187 | A-Award | A | 129,187 | 0.00 | 0.00 |
| 2022-06-21 | Powchik Peter | director: | 129,187 | A-Award | A | 129,187 | 0.00 | 0.00 |
| 2022-06-21 | BLATT GREGORY R | director: | 129,187 | A-Award | A | 129,187 | 0.00 | 0.00 |
| 2022-06-21 | BLATT GREGORY R | director | 129,187 | A-Award | A | 129,187 | 2.09 | 270,001.00 |
| 2022-01-24 | Diamandis Peter | director | 430,604 | F-InKind | D | 312,659 | 8.60 | 2,688,867.00 |
| 2021-11-18 | Diamandis Peter | director | 90,499 | S-Sale | D | 248 | 13.00 | 3,224.00 |
| 2021-11-15 | Diamandis Peter | director | 13,824 | C-Conversion | A | 13,824 | 0.00 | 0.00 |
| 2021-11-15 | Diamandis Peter | director | 0 | C-Conversion | D | 21,511 | 0.00 | 0.00 |
| 2021-11-10 | Diamandis Peter | director | 0 | D | 13,824 | 0.00 | 0.00 | |
| 2022-06-16 | Reese Lou | officer: Executive Chairman | 51,737,344 | P-Purchase | A | 100,000 | 1.99 | 199,290.00 |
| 2022-06-16 | Hu Mei Mei | officer: See Remarks | 51,737,344 | P-Purchase | A | 100,000 | 1.99 | 199,290.00 |
| 2022-06-16 | UNITED BIOMEDICAL INC | director: | 51,737,344 | P-Purchase | A | 100,000 | 1.99 | 199,290.00 |
| 2022-06-10 | Sloss Dakin | director: | 851,152 | S-Sale | D | 8,193 | 2.43 | 19,875.00 |
| 2022-06-08 | UNITED BIOMEDICAL INC | director: | 51,637,344 | P-Purchase | A | 10,978 | 2.72 | 29,852.00 |
| 2022-06-08 | Hu Mei Mei | officer: See Remarks | 51,637,344 | P-Purchase | A | 10,978 | 2.72 | 29,852.00 |
| 2022-06-08 | Reese Lou | officer: Executive Chairman | 51,626,366 | P-Purchase | A | 10,000 | 2.95 | 29,534.00 |
| 2022-05-03 | Guirakhoo Farshad | officer: Chief Scientific Officer | 116,730 | M-Exempt | D | 10,000 | 0.57 | 5,700.00 |
| 2022-05-03 | Guirakhoo Farshad | officer: Chief Scientific Officer | 10,000 | M-Exempt | A | 10,000 | 0.57 | 5,700.00 |
| 2022-04-26 | UNITED BIOMEDICAL INC | director: | 51,616,366 | P-Purchase | A | 4,807 | 3.58 | 17,222.00 |
| 2022-04-26 | Reese Lou | officer: Executive Chairman | 51,616,366 | P-Purchase | A | 4,807 | 3.58 | 17,222.00 |
| 2022-04-26 | Hu Mei Mei | officer: See Remarks | 51,616,366 | P-Purchase | A | 4,807 | 3.58 | 17,222.00 |
| 2022-04-25 | Hu Mei Mei | officer: See Remarks | 51,593,454 | P-Purchase | A | 8,038 | 3.37 | 27,073.00 |
| 2022-04-25 | Reese Lou | officer: Executive Chairman | 51,593,454 | P-Purchase | A | 8,038 | 3.37 | 27,073.00 |
| 2022-04-25 | UNITED BIOMEDICAL INC | director: | 5,193,454 | P-Purchase | A | 8,038 | 3.37 | 27,073.00 |
| 2022-03-31 | Powchik Peter | director: | 94,186 | A-Award | A | 94,186 | 0.00 | 0.00 |
| 2022-03-31 | Powchik Peter | director | 225,858 | D | 0 | 0.00 | 0.00 | |
| 2022-03-15 | Palm Ulo | officer: Chief Medical Officer | 100,000 | A-Award | A | 100,000 | 0.00 | 0.00 |
| 2022-01-24 | Diamandis Peter | director | 729,687 | M-Exempt | A | 652,764 | 4.12 | 2,688,865.00 |
| 2022-01-24 | Diamandis Peter | director | 163,191 | M-Exempt | D | 652,764 | 4.12 | 2,688,865.00 |
| 2022-01-03 | Pesile Jason | officer: See Remarks | 51,225 | A-Award | A | 51,225 | 5.96 | 305,301.00 |
| 2022-01-03 | Pesile Jason | officer | 0 | 0 | 0.00 | 0.00 | ||
| 2021-12-31 | Chui James | director | 14,000 | P-Purchase | A | 6,000 | 5.48 | 32,880.00 |
| 2022-01-03 | HORNIG GEORGE R | director | 67,953 | A-Award | A | 67,953 | 5.96 | 405,000.00 |
| 2022-01-03 | HORNIG GEORGE R | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2021-12-10 | Chui James | director | 8,000 | P-Purchase | A | 8,000 | 7.89 | 63,120.00 |
| 2021-11-16 | BLATT GREGORY R | director | 76,923 | J-Other | A | 76,923 | 0.00 | 0.00 |
| 2021-11-16 | BLATT GREGORY R | director | 0 | J-Other | D | 76,923 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
